4//SEC Filing
Miller Vincent A. 4
Accession 0001567619-20-017293
CIK 0001628171other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 8:33 PM ET
Size
7.3 KB
Accession
0001567619-20-017293
Insider Transaction Report
Form 4
Miller Vincent A.
Director
Transactions
- Sale
Common Stock
2020-09-28$34.11/sh−5,300$180,772→ 26,833 total - Sale
Common Stock
2020-09-29$34.07/sh−450$15,332→ 26,383 total
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $34.00 to $34.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,808 Restricted Stock Units.
- [F4]The transaction was executed in multiple trades in prices ranging from $34.00 to $34.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001584999
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 8:33 PM ET
- Size
- 7.3 KB